Literature DB >> 1396697

The binding of mutant actins to profilin, ATP and DNase I.

D R Drummond1, E S Hennessey, J C Sparrow.   

Abstract

Twenty-five mutations were created in the Drosophila melanogaster Act88F actin gene by in vitro mutagenesis and the mutant actins expressed in vitro. The affinity of the mutant actins for ATP, profilin and DNase I was determined. They were also tested for conformational changes by non-denaturing gel electrophoresis. Mutations at positions 364 (highly conserved) and 366 (invariant) caused changes in conformation, reduced ATP binding and increased profilin binding. At position 362 (invariant) only the conservative change from tyrosine to phenylalanine had no effect; other changes at this position affected conformation, ATP and profilin binding. Although only glycine or serine occur naturally at position 368, changes to threonine or glutamine had no effect on the actin. The mutant in which Asp363 was replaced by His and that in which Glu364 was replaced by Lys decreased DNase I binding, yet neither amino acid occurs in the DNase I binding site. Likewise several mutations affect ATP and profilin binding but are distant from the binding sites. We conclude that, although actin has a highly conserved amino acid sequence, individual amino acids can have variable tolerance for substitutions. Also amino acid changes can exert significant effects on the binding of ligands to distant parts of the actin structure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396697     DOI: 10.1111/j.1432-1033.1992.tb17274.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  A mutant of Arp2p causes partial disassembly of the Arp2/3 complex and loss of cortical actin function in fission yeast.

Authors:  J L Morrell; M Morphew; K L Gould
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

2.  Intermolecular coupling between loop 38-52 and the C-terminus in actin filaments.

Authors:  E Kim; E Reisler
Journal:  Biophys J       Date:  1996-10       Impact factor: 4.033

3.  Long-range conformational effects of proteolytic removal of the last three residues of actin.

Authors:  H Strzelecka-Gołaszewska; M Mossakowska; A Woźniak; J Moraczewska; H Nakayama
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

Review 4.  Molecular genetics of actin function.

Authors:  E S Hennessey; D R Drummond; J C Sparrow
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

5.  Structural connectivity in actin: effect of C-terminal modifications on the properties of actin.

Authors:  R H Crosbie; C Miller; P Cheung; T Goodnight; A Muhlrad; E Reisler
Journal:  Biophys J       Date:  1994-11       Impact factor: 4.033

6.  A heterozygous mutation of beta-actin associated with neutrophil dysfunction and recurrent infection.

Authors:  H Nunoi; T Yamazaki; H Tsuchiya; S Kato; H L Malech; I Matsuda; S Kanegasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

7.  A mutation in the gamma actin 1 (ACTG1) gene causes autosomal dominant hearing loss (DFNA20/26).

Authors:  E van Wijk; E Krieger; M H Kemperman; E M R De Leenheer; P L M Huygen; C W R J Cremers; F P M Cremers; H Kremer
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

8.  ADP-ribosylation of Drosophila indirect-flight-muscle actin and arthrin by Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin.

Authors:  I Just; E S Hennessey; D R Drummond; K Aktories; J C Sparrow
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

9.  Differential epitope tagging of actin in transformed Drosophila produces distinct effects on myofibril assembly and function of the indirect flight muscle.

Authors:  V Brault; U Sauder; M C Reedy; U Aebi; C A Schoenenberger
Journal:  Mol Biol Cell       Date:  1999-01       Impact factor: 4.138

10.  Subdomain location of mutations in cardiac actin correlate with type of functional change.

Authors:  Maureen M Mundia; Ryan W Demers; Melissa L Chow; Alexandru A Perieteanu; John F Dawson
Journal:  PLoS One       Date:  2012-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.